• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Validation and demonstration of a new comprehensive model of Alzheimer's disease progression.验证和展示一种新的阿尔茨海默病进展综合模型。
Alzheimers Dement. 2021 Oct;17(10):1698-1708. doi: 10.1002/alz.12336. Epub 2021 May 14.
2
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.临床前阿尔茨海默病及其结局:一项纵向队列研究。
Lancet Neurol. 2013 Oct;12(10):957-65. doi: 10.1016/S1474-4422(13)70194-7. Epub 2013 Sep 4.
3
Clinical outcomes of possible versus probable Alzheimer's disease.可能型与很可能型阿尔茨海默病的临床结局
Neurology. 2003 Sep 9;61(5):661-7. doi: 10.1212/wnl.61.5.661.
4
Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.验证一个多变量预测模型在社区居住的多民族队列中阿尔茨海默病的临床进展。
J Alzheimers Dis. 2023;95(1):93-117. doi: 10.3233/JAD-220811.
5
Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.轻度认知障碍中的抑郁与阿尔茨海默病的进展相关:一项纵向研究。
J Alzheimers Dis. 2014;42(4):1239-50. doi: 10.3233/JAD-140405.
6
Personalized predictive modeling for patients with Alzheimer's disease using an extension of Sullivan's life table model.利用沙利文寿命表模型的扩展,对阿尔茨海默病患者进行个性化预测建模。
Alzheimers Res Ther. 2017 Sep 20;9(1):75. doi: 10.1186/s13195-017-0302-6.
7
Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.阿尔茨海默病生物标志物日常实践(ABIDE)项目中个体轻度认知障碍患者生物标志物结果的解读
JAMA Neurol. 2017 Dec 1;74(12):1481-1491. doi: 10.1001/jamaneurol.2017.2712.
8
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.年龄相关性阿尔茨海默病风险的基因评估:多基因风险评分的开发与验证
PLoS Med. 2017 Mar 21;14(3):e1002258. doi: 10.1371/journal.pmed.1002258. eCollection 2017 Mar.
9
Progression along data-driven disease timelines is predictive of Alzheimer's disease in a population-based cohort.基于人群队列研究,沿着数据驱动的疾病时间线进展可预测阿尔茨海默病。
Neuroimage. 2021 Sep;238:118233. doi: 10.1016/j.neuroimage.2021.118233. Epub 2021 Jun 4.
10
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study.基于生物标志物的轻度认知障碍患者预后预测(ABIDE):一项建模研究。
Lancet Neurol. 2019 Nov;18(11):1034-1044. doi: 10.1016/S1474-4422(19)30283-2. Epub 2019 Sep 13.

引用本文的文献

1
Development and validation of a clinical prediction tool to estimate survival in community-dwelling adults living with dementia: a protocol.开发和验证一种用于估计社区居住的痴呆症患者生存的临床预测工具的方案。
BMJ Open. 2024 Nov 17;14(11):e086231. doi: 10.1136/bmjopen-2024-086231.
2
Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology.在阿尔茨海默病测序项目中解析阿尔茨海默病神经精神症状的遗传基础:研究设计与方法
Alzheimers Dement (Amst). 2024 Aug 23;16(3):e70000. doi: 10.1002/dad2.70000. eCollection 2024 Jul-Sep.
3
Trajectories and Transitions in Service Use Among Older Veterans at High Risk of Long-Term Institutional Care.高风险长期机构护理的老年退伍军人的服务使用轨迹和转变。
Med Care. 2024 Oct 1;62(10):650-659. doi: 10.1097/MLR.0000000000002051. Epub 2024 Aug 12.
4
Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.验证一个多变量预测模型在社区居住的多民族队列中阿尔茨海默病的临床进展。
J Alzheimers Dis. 2023;95(1):93-117. doi: 10.3233/JAD-220811.
5
Associations between cognitive function and a range of significant life events in an elderly essential tremor cohort study.老年特发性震颤队列研究中认知功能与一系列重大生活事件的相关性。
J Neurol Sci. 2023 Jul 15;450:120675. doi: 10.1016/j.jns.2023.120675. Epub 2023 May 11.
6
Expanding the scope of health disparities research in Alzheimer's disease and related dementias: Recommendations from the "Leveraging Existing Data and Analytic Methods for Health Disparities Research Related to Aging and Alzheimer's Disease and Related Dementias" Workshop Series.扩大阿尔茨海默病及相关痴呆症健康差异研究的范围:“利用现有数据和分析方法开展与衰老、阿尔茨海默病及相关痴呆症相关的健康差异研究”系列研讨会的建议
Alzheimers Dement (Amst). 2023 Mar 16;15(1):e12415. doi: 10.1002/dad2.12415. eCollection 2023 Jan-Mar.

本文引用的文献

1
Understanding and predicting the longitudinal course of dementia.理解和预测痴呆的纵向病程。
Curr Opin Psychiatry. 2019 Mar;32(2):123-129. doi: 10.1097/YCO.0000000000000482.
2
Personalized predictive modeling for patients with Alzheimer's disease using an extension of Sullivan's life table model.利用沙利文寿命表模型的扩展,对阿尔茨海默病患者进行个性化预测建模。
Alzheimers Res Ther. 2017 Sep 20;9(1):75. doi: 10.1186/s13195-017-0302-6.
3
The Predictors study: Development and baseline characteristics of the Predictors 3 cohort.预测因素研究:预测因素3队列的发展及基线特征
Alzheimers Dement. 2017 Jan;13(1):20-27. doi: 10.1016/j.jalz.2016.04.004. Epub 2016 May 21.
4
Assessing Fluctuating Cognition in Dementia Diagnosis: Interrater Reliability of the Clinician Assessment of Fluctuation.痴呆诊断中波动认知的评估:临床医生波动评估的评分者间信度
Am J Alzheimers Dis Other Demen. 2016 Mar;31(2):137-43. doi: 10.1177/1533317515603359. Epub 2015 Sep 3.
5
A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients.用于预测阿尔茨海默病患者疾病终点时间的新算法。
J Alzheimers Dis. 2014;38(3):661-8. doi: 10.3233/JAD-131142.
6
Survival in dementia and predictors of mortality: a review.痴呆患者的生存状况及其死亡预测因素:综述。
Int J Geriatr Psychiatry. 2013 Nov;28(11):1109-24. doi: 10.1002/gps.3946. Epub 2013 Mar 22.
7
Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.模型透明度和验证:ISPOR-SMDM 建模良好实践工作组的报告——7.
Value Health. 2012 Sep-Oct;15(6):843-50. doi: 10.1016/j.jval.2012.04.012.
8
Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia.痴呆患者的死亡时间:对痴呆患者生存时间和生命损失年数的系统文献回顾。
Int Psychogeriatr. 2012 Jul;24(7):1034-45. doi: 10.1017/S1041610211002924. Epub 2012 Feb 13.
9
Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progression.基于模型的阿尔茨海默病经济学评价:对用于模拟阿尔茨海默病进展的方法的综述。
Value Health. 2011 Jul-Aug;14(5):621-30. doi: 10.1016/j.jval.2010.12.008.
10
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.阿尔茨海默病所致痴呆的诊断:美国国家老龄化研究所-阿尔茨海默病协会工作组关于阿尔茨海默病诊断指南的建议。
Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.

验证和展示一种新的阿尔茨海默病进展综合模型。

Validation and demonstration of a new comprehensive model of Alzheimer's disease progression.

机构信息

Cognitive Neuroscience Division of the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Biodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, North Carolina, USA.

出版信息

Alzheimers Dement. 2021 Oct;17(10):1698-1708. doi: 10.1002/alz.12336. Epub 2021 May 14.

DOI:10.1002/alz.12336
PMID:33991041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8818260/
Abstract

INTRODUCTION

Identifying the course of Alzheimer's disease (AD) for individual patients is important for numerous clinical applications. Ideally, prognostic models should provide information about a range of clinical features across the entire disease process. Previously, we published a new comprehensive longitudinal model of AD progression with inputs/outputs covering 11 interconnected clinical measurement domains.

METHODS

Here, we (1) validate the model on an independent cohort; and (2) demonstrate the model's utility in clinical applications by projecting changes in 6 of the 11 domains.

RESULTS

Survival and prevalence curves for two representative outcomes-mortality and dependency-generated by the model accurately reproduced the observed curves both overall and for patients subdivided according to risk levels using an independent Cox model.

DISCUSSION

The new model, validated here, effectively reproduces the observed course of AD from an initial visit assessment, allowing users to project coordinated developments for individual patients of multiple disease features.

摘要

简介

确定个体患者的阿尔茨海默病(AD)病程对于许多临床应用非常重要。理想情况下,预后模型应提供有关整个疾病过程中一系列临床特征的信息。此前,我们发表了一种新的 AD 进展综合纵向模型,其输入/输出涵盖 11 个相互关联的临床测量领域。

方法

在这里,我们(1)在独立队列中验证模型;(2)通过预测 11 个领域中的 6 个领域的变化,展示模型在临床应用中的实用性。

结果

模型生成的两个代表性结果——死亡率和依赖性的生存和患病率曲线,无论是整体还是根据风险水平使用独立 Cox 模型细分的患者,都准确地再现了观察到的曲线。

讨论

在此验证的新模型有效地再现了从初始就诊评估中观察到的 AD 病程,允许用户预测多个疾病特征的个体患者的协调发展。